ArticleFrontiers in neurology2024

Risk of malignancy and the use of disease-modifying therapy in multiple sclerosis: exploring the role of DMT in a multi-center study.

Mohammed Bayounis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.